<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38510249</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Coagulation profile in hospitalized children with COVID-19: pediatric age dependency and its impact on long COVID development.</ArticleTitle><Pagination><StartPage>1363410</StartPage><MedlinePgn>1363410</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1363410</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1363410</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Pulmonary endotheliopathy and microvascular immunothrombosis play a key role in acute COVID-19. Moreover, persistent endotheliopathy and heightened coagulability frequently occur in individuals recovering from COVID-19, suggesting the intriguing possibility of their role in the development of long COVID. The aim of our study was to investigate the coagulation profile in patients with COVID-19 based on age and their role in the development of long COVID.</AbstractText><AbstractText Label="METHODS">We conducted a prospective single-center cohort study from September 2022 to August 2023. The study involved 190 patients younger than 18 years who were hospitalized at the Ternopil City Children's Hospital, Ukraine due to COVID-19. Patients underwent determination of coagulation profile in addition to the general clinical examination. After discharge from the hospital, patients were monitored for the presence of long COVID symptoms. Among the 157 participants who consented for follow-up, 62 patients (39.5%) had long COVID symptoms according to the WHO definition, while the rest (95 patients) did not have symptoms of long COVID (fully recovered).</AbstractText><AbstractText Label="RESULTS">The study revealed the normal count of platelets in the majority of patients (86.8%), whereas abnormalities in the coagulation profile were revealed in 94.5% of children with COVID-19, and these changes were age-dependent. The patients were mostly presented with increased activated partial thromboplastin time (69.1%), prothrombin time (PT) (39.8%) and D-dimer (45.0%). There was no significant difference between the median of platelet levels and coagulation profile indicators between the groups with long COVID and recovered. Among children who developed persistent long COVID symptoms there was a statistically higher percentage of abnormal PT values (53% versus 36.1%, p=0.0432), with no significant differences in other coagulation profile indicators. Abnormal PT along with female gender, comorbidities, especially allergic pathology, nutritional disorder, including obesity, were determined as potential risk factors of the long COVID development (Odds ratio - 2.0611; 95% 1.0179-4.1737, p=0.0445).</AbstractText><AbstractText Label="CONCLUSIONS">The study highlights the need for more extensive research into the coagulation profiles of pediatric populations, considering age-specific factors. This could enhance our understanding of thromboinflammation in COVID-19 and its potential contribution to the development of persistent symptoms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Boyarchuk, Perestiuk, Kosovska and Volianska.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Boyarchuk</LastName><ForeName>Oksana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Children's Diseases and Pediatric Surgery, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Perestiuk</LastName><ForeName>Vita</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Children's Diseases and Pediatric Surgery, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosovska</LastName><ForeName>Tetyana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Children's Diseases and Pediatric Surgery, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volianska</LastName><ForeName>Liubov</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Children's Diseases and Pediatric Surgery, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002673" MajorTopicYN="N">Child, Hospitalized</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001778" MajorTopicYN="Y">Blood Coagulation Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">coagulation profile</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>21</Day><Hour>4</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38510249</ArticleId><ArticleId IdType="pmc">PMC10950941</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1363410</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fernandes DM, Oliveira CR, Guerguis S, Eisenberg R, Choi J, Kim M, et al. . Tri-state pediatric COVID-19 research consortium. Severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth. J Pediatr. (2021) 230:23&#x2013;31.e10. doi:&#xa0;10.1016/j.jpeds.2020.11.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.11.016</ArticleId><ArticleId IdType="pmc">PMC7666535</ArticleId><ArticleId IdType="pubmed">33197493</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. . Irish COVID-19 Vasculopathy Study (iCVS) investigators. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. (2021) 19:2546&#x2013;53. doi:&#xa0;10.1111/jth.15490</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoon JW, Grijalva CG, Thurm C, Richardson T, Spaulding AB, Teufel RJ, 2nd, et al. . Factors associated with COVID-19 disease severity in US children and adolescents. J Hosp Med. (2021) 16:603&#x2013;10. doi:&#xa0;10.12788/jhm.3689</Citation><ArticleIdList><ArticleId IdType="doi">10.12788/jhm.3689</ArticleId><ArticleId IdType="pmc">PMC8494279</ArticleId><ArticleId IdType="pubmed">34613896</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisler G, Izard SM, Shah S, Lewis D, Kainth MK, Hagmann SHF, et al. . Characteristics and risk factors associated with critical illness in pediatric COVID-19. Ann Intensive Care. (2020) 10:171. doi:&#xa0;10.1186/s13613-020-00790-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00790-5</ArticleId><ArticleId IdType="pmc">PMC7749393</ArticleId><ArticleId IdType="pubmed">33340348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim L, Whitaker M, O&#x2019;Halloran A, Kambhampati A, Chai SJ, Reingold A, et al. . Hospitalization rates and characteristics of children aged &lt;18 years hospitalized with laboratory-confirmed COVID-19 - COVID-NET, 14 states, march 1-july 25, 2020. MMWR Morb Mortal Wkly Rep. (2020) 69:1081&#x2013;8. doi:&#xa0;10.15585/mmwr.mm6932e3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6932e3</ArticleId><ArticleId IdType="pmc">PMC7440125</ArticleId><ArticleId IdType="pubmed">32790664</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. . Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open. (2021) 4:e2111182. doi:&#xa0;10.1001/jamanetworkopen.2021.11182</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11182</ArticleId><ArticleId IdType="pmc">PMC8185607</ArticleId><ArticleId IdType="pubmed">34097050</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff RC, Campbell AP, Taylor CA, Chai SJ, Kawasaki B, Meek J, et al. . Risk factors for severe COVID-19 in children. Pediatrics. (2022) 149:e2021053418. doi:&#xa0;10.1542/peds.2021-053418</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-053418</ArticleId><ArticleId IdType="pmc">PMC9213563</ArticleId><ArticleId IdType="pubmed">34935038</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Chen R, Liu C, Liang W, Guan W, Tang R, et al. . Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. (2020) 7:e362&#x2013;3. doi:&#xa0;10.1016/S2352-3026(20)30109-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30109-5</ArticleId><ArticleId IdType="pmc">PMC7158946</ArticleId><ArticleId IdType="pubmed">32278361</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. (2020) 323:1061&#x2013;9. doi:&#xa0;10.1001/jama.2020.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Ni Cheallaigh C, Bergin C, Martin-Loeches I, Browne P, et al. . COVID-19 coagulopathy in Caucasian patients. Br J Haematol. (2020) 189:1044&#x2013;9. doi:&#xa0;10.1111/bjh.16749</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16749</ArticleId><ArticleId IdType="pmc">PMC7264579</ArticleId><ArticleId IdType="pubmed">32330308</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, et al. . COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. (2020) 120:998&#x2013;1000. doi:&#xa0;10.1055/s-0040-1710018</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1710018</ArticleId><ArticleId IdType="pmc">PMC7295272</ArticleId><ArticleId IdType="pubmed">32316063</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. . Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. (2020) 18:1738&#x2013;42. doi:&#xa0;10.1111/jth.14850</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14850</ArticleId><ArticleId IdType="pmc">PMC9906150</ArticleId><ArticleId IdType="pubmed">32302438</ArticleId></ArticleIdList></Reference><Reference><Citation>Teimury A, Khameneh MT, Khaledi EM. Major coagulation disorders and parameters in COVID19 patients. Eur J Med Res. (2022) 27:25. doi:&#xa0;10.1186/s40001-022-00655-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-022-00655-6</ArticleId><ArticleId IdType="pmc">PMC8845229</ArticleId><ArticleId IdType="pubmed">35168674</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzun G, Althaus K, Hammer S, Bakchoul T. Assessment and monitoring of coagulation in patients with COVID-19: A review of current literature. Hamostaseologie. (2022) 42:409&#x2013;19. doi:&#xa0;10.1055/a-1755-8676</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1755-8676</ArticleId><ArticleId IdType="pubmed">35477118</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaumenhaft R, Enjyoji K, Schmaier AA. Vasculopathy in COVID-19. Blood. (2022) 140:222&#x2013;35. doi:&#xa0;10.1182/blood.2021012250</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012250</ArticleId><ArticleId IdType="pmc">PMC8736280</ArticleId><ArticleId IdType="pubmed">34986238</ArticleId></ArticleIdList></Reference><Reference><Citation>Aid M, Busman-Sahay K, Vidal SJ, Maliga Z, Bondoc S, Starke C, et al. . Vascular disease and thrombosis in SARS-coV-2-infected rhesus macaques. Cell. (2020) 183:1354&#x2013;66 e13. doi:&#xa0;10.1016/j.cell.2020.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7546181</ArticleId><ArticleId IdType="pubmed">33065030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinkovits G, Mezo B, Reti M, Muller V, Ivanyi Z, Gal J, et al. . Complement overactivation and consumption predicts in-hospital mortality in SARS-coV-2 infection. Front Immunol. (2021) 12:663187. doi:&#xa0;10.3389/fimmu.2021.663187</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.663187</ArticleId><ArticleId IdType="pmc">PMC8027327</ArticleId><ArticleId IdType="pubmed">33841446</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza G, Campia U, Hurwitz S, Snyder JE, Rizzo SM, Pfeferman MB, et al. . Registry of arterial and venous thromboembolic complications in patients with COVID-19. J Am Coll Cardiol. (2020) 76:2060&#x2013;72. doi:&#xa0;10.1016/j.jacc.2020.08.070</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.070</ArticleId><ArticleId IdType="pmc">PMC7588178</ArticleId><ArticleId IdType="pubmed">33121712</ArticleId></ArticleIdList></Reference><Reference><Citation>Katneni UK, Alexaki A, Hunt RC, Schiller T, DiCuccio M, Buehler PW, et al. . Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus. Thromb Haemost. (2020) 120:1668&#x2013;79. doi:&#xa0;10.1055/s-0040-1715841</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1715841</ArticleId><ArticleId IdType="pmc">PMC7869056</ArticleId><ArticleId IdType="pubmed">32838472</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell WB, Davila J, Keenan J, Jackson J, Tal A, Morrone KA, et al. . Children and young adults hospitalized for severe COVID-19 exhibit thrombotic coagulopathy. Pediatr Blood Cancer. (2021) 68:e28975. doi:&#xa0;10.1002/pbc.28975</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.28975</ArticleId><ArticleId IdType="pmc">PMC7994974</ArticleId><ArticleId IdType="pubmed">33661561</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenberg NA, Sochet A, Albisetti M, Biss T, Bonduel M, Jaffray J, et al. . Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness. J Thromb Haemost. (2020) 18:3099&#x2013;105. doi:&#xa0;10.1111/jth.15073</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15073</ArticleId><ArticleId IdType="pmc">PMC9906345</ArticleId><ArticleId IdType="pubmed">33174388</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyarchuk O, Predyk L, Yuryk I. COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity. Reumatologia. (2021) 59:197&#x2013;9. doi:&#xa0;10.5114/reum.2021.107590</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/reum.2021.107590</ArticleId><ArticleId IdType="pmc">PMC8436806</ArticleId><ArticleId IdType="pubmed">34538947</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L, Kaiser R, Stark K. Thromboinflammation in long COVID-the elusive key to postinfection sequelae. J Thromb Haemostasis: JTH. (2023) 21:2020&#x2013;31. doi:&#xa0;10.1016/j.jtha.2023.04.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2023.04.039</ArticleId><ArticleId IdType="pmc">PMC10174338</ArticleId><ArticleId IdType="pubmed">37178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang A, Leng Y, Zhang Y, Wu K, Ji Y, Lei S, et al. . Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19. Int J Infect Dis. (2020) 100:441&#x2013;8. doi:&#xa0;10.1016/j.ijid.2020.09.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.021</ArticleId><ArticleId IdType="pmc">PMC7490635</ArticleId><ArticleId IdType="pubmed">32947052</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan BE, Wong SW, Sum CLL, Lim GH, Leung BP, Tan CW, et al. . COVID-19 Clotting and Bleeding Investigators. Hypercoagulability, endotheliopathy, and inflammation approximating 1&#x2009;year after recovery: Assessing the long-term outcomes in COVID-19 patients. Am J Hematol. (2022) 97:915&#x2013;23. doi:&#xa0;10.1002/ajh.26575</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26575</ArticleId><ArticleId IdType="pmc">PMC9073976</ArticleId><ArticleId IdType="pubmed">35477923</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization . Post COVID-19 condition (Long COVID)(2023). Available online at: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition#:~:text=It%20is%20defined%20as%20the,months%20with%20no%20other%20explanation (Accessed on 11 July 2023).</Citation></Reference><Reference><Citation>Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, et al. . Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. (2023) 151:e2022060640. doi:&#xa0;10.1542/peds.2022-060640</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-060640</ArticleId><ArticleId IdType="pubmed">36622115</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institutes of Health (NIH) . COVID-19 treatment guidelines (2023). Available online at: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/ (Accessed on 6 March 2023).</Citation></Reference><Reference><Citation>Noni M, Koukou DM, Tritzali M, Kanaka-Gantenbein C, Michos A, Spoulou V. Coagulation abnormalities and management in hospitalized pediatric patients with COVID-19. Pediatr Infect Dis J. (2022) 41:570&#x2013;4. doi:&#xa0;10.1097/INF.0000000000003545</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003545</ArticleId><ArticleId IdType="pmc">PMC9177125</ArticleId><ArticleId IdType="pubmed">35389967</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X, Duan Y, Bao T, Gu J, Chen Y, Li Y, et al. . The values of coagulation function in COVID-19 patients. PloS One. (2020) 15:e0241329. doi:&#xa0;10.1371/journal.pone.0241329</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241329</ArticleId><ArticleId IdType="pmc">PMC7595402</ArticleId><ArticleId IdType="pubmed">33119703</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes Gil M, Gonzalez-Lugo JD, Rahman S, Barouqa M, Szymanski J, Ikemura K, et al. . Correlation of coagulation parameters with clinical outcomes during the coronavirus-19 surge in new york: observational cohort. Front Physiol. (2021) 12:618929. doi:&#xa0;10.3389/fphys.2021.618929</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.618929</ArticleId><ArticleId IdType="pmc">PMC7940374</ArticleId><ArticleId IdType="pubmed">33708136</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo HC, You CY, Lu SW, Fu YQ. Characteristics coagulation alteration in patients with COVID-19. Ann Hematol. (2021) 100:45&#x2013;52. doi:&#xa0;10.1007/s00277-020-04305-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04305-x</ArticleId><ArticleId IdType="pmc">PMC7572245</ArticleId><ArticleId IdType="pubmed">33079220</ArticleId></ArticleIdList></Reference><Reference><Citation>Velasco-Rodr&#xed;guez D, Alonso-Dominguez JM, Vidal Laso R, Lainez-Gonz&#xe1;lez D, Garc&#xed;a-Raso A, Mart&#xed;n-Herrero S, et al. . Development and validation of a predictive model of in-hospital mortality in COVID-19 patients. PloS One. (2021) 16:e0247676. doi:&#xa0;10.1371/journal.pone.0247676</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247676</ArticleId><ArticleId IdType="pmc">PMC7932507</ArticleId><ArticleId IdType="pubmed">33661939</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang G, Hao S, Fu C, Hu W, Xie L, Wu Q, et al. . The effect of coagulation factors in 2019 novel coronavirus patients: A systematic review and meta-analysis. Med (Baltimore). (2021) 100:e24537. doi:&#xa0;10.1097/MD.0000000000024537</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000024537</ArticleId><ArticleId IdType="pmc">PMC7899891</ArticleId><ArticleId IdType="pubmed">33607784</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Mariani F, Pierri L, Morello R, Yock-Corrales A, Del Aguila O, et al. . Association between coagulation profile and clinical outcome in children with SARS-CoV-2 infection or MIS-C: A multicenter cross-sectional study. Children (Basel). (2022) 9:279. doi:&#xa0;10.3390/children9020279</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9020279</ArticleId><ArticleId IdType="pmc">PMC8870084</ArticleId><ArticleId IdType="pubmed">35204999</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflammation Res. (2020) 69:1181&#x2013;9. doi:&#xa0;10.1007/s00011-020-01401-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01401-6</ArticleId><ArticleId IdType="pmc">PMC7486586</ArticleId><ArticleId IdType="pubmed">32918567</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, Iba T. COVID-19 coagulopathy: is it disseminated intravascular coagulation? Intern Emerg Med. (2021) 16:309&#x2013;12. doi:&#xa0;10.1007/s11739-020-02601-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02601-y</ArticleId><ArticleId IdType="pmc">PMC7758412</ArticleId><ArticleId IdType="pubmed">33368021</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro L, Valentini P, Sorrentino S, Ferretti MA, De Candia E, Basso M, et al. . Extended coagulation profile of children with Long Covid: a prospective study. Sci Rep. (2022) 12:18392. doi:&#xa0;10.1038/s41598-022-23168-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-23168-y</ArticleId><ArticleId IdType="pmc">PMC9626616</ArticleId><ArticleId IdType="pubmed">36319840</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. . COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. (2020) 75:2950&#x2013;73. doi:&#xa0;10.1016/j.jacc.2020.04.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Franchini M, Montagnana M, Guidi GC. Coagulation testing in pediatric patients: the young are not just miniature adults. Semin Thromb Hemost. (2007) 33:816&#x2013;20. doi:&#xa0;10.1055/s-2007-1000373</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-1000373</ArticleId><ArticleId IdType="pubmed">18175287</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng D, Zhang J, Ji Y, Pan D. Risk factors for redetectable positivity in recovered COVID-19 children. Pediatr Pulmonol. (2020) 55:3602&#x2013;9. doi:&#xa0;10.1002/ppul.25116</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25116</ArticleId><ArticleId IdType="pmc">PMC7675449</ArticleId><ArticleId IdType="pubmed">33049115</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini G, Selleri V, Roncati L, Coppi F, Nasi M, Farinetti A, et al. . Vascular &#x201c;Long COVID&#x201d;: A new vessel disease? Angiology. (2024) 75:8&#x2013;14. doi:&#xa0;10.1177/00033197231153204</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197231153204</ArticleId><ArticleId IdType="pmc">PMC9895315</ArticleId><ArticleId IdType="pubmed">36652923</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, de Oliveira MHS, Peligro PJ, Velasco JV, Macaranas I, Ver AT, et al. . Age, sex and previous comorbidities as risk factors not associated with SARS-coV-2 infection for long COVID-19: A systematic review and meta-analysis. J Clin Med. (2022) 11:7314. doi:&#xa0;10.3390/jcm11247314</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Volianska L, Burbela E, Kosovska T, Perestyuk V, Boyarchuk O. The role of vitamin D in the course of SARS-CoV-2 infection and long COVID in children (literature review). CHILD`S Health. (2023) 18:225&#x2013;30. doi:&#xa0;10.22141/2224-0551.18.3.2023.1590</Citation><ArticleIdList><ArticleId IdType="doi">10.22141/2224-0551.18.3.2023.1590</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng YB, Zeng N, Yuan K, Tian SS, Yang YB, Gao N, et al. . Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review. J Infect Public Health. (2023) 16:660&#x2013;72. doi:&#xa0;10.1016/j.jiph.2023.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.03.005</ArticleId><ArticleId IdType="pmc">PMC9990879</ArticleId><ArticleId IdType="pubmed">36931142</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ven D, Bulu&#x15f; AD. Clinical and laboratory predictors of long-COVID in children: a single center retrospective study. Eur Rev Med Pharmacol Sci. (2022) 26:7695&#x2013;704. doi:&#xa0;10.26355/eurrev_202210_30046</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202210_30046</ArticleId><ArticleId IdType="pubmed">36314341</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. . Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. (2021) 27:1507&#x2013;13. doi:&#xa0;10.1016/j.cmi.2021.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). (2021) 53:737&#x2013;54. doi:&#xa0;10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Maamar M, Artime A, Pariente E, Fierro P, Ruiz Y, Guti&#xe9;rrez S, et al. . Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr Med Res Opin. (2022) 38:901&#x2013;9. doi:&#xa0;10.1080/03007995.2022.2042991</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2042991</ArticleId><ArticleId IdType="pmc">PMC8935459</ArticleId><ArticleId IdType="pubmed">35166141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicco S, Cicco G, Racanelli V, Vacca A. Neutrophil extracellular traps (NETs) and damage-associated molecular patterns (DAMPs): two potential targets for COVID-19 treatment. Mediators Inflamm. (2020) 2020:7527953. doi:&#xa0;10.1155/2020/7527953</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/7527953</ArticleId><ArticleId IdType="pmc">PMC7366221</ArticleId><ArticleId IdType="pubmed">32724296</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. . Chronic inflammation in the etiology of disease across the life span. Nat Med. (2019) 25:1822&#x2013;32. doi:&#xa0;10.1038/s41591-019-0675-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0675-0</ArticleId><ArticleId IdType="pmc">PMC7147972</ArticleId><ArticleId IdType="pubmed">31806905</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>